Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prednisone Acetate”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT01786265
What this trial is testing

Finite Androgen Ablation With or Without Abiraterone Acetate and Prednisone in Treating Patients With Recurrent Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaRecurrent Prostate Carcinoma
M.D. Anderson Cancer Center 310
Testing effectiveness (Phase 2)Study completedNCT01023061
What this trial is testing

Abiraterone Prednisone and Hormonal Therapy Before and During Radiation Therapy in Localized Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateStage II Prostate CancerStage III Prostate Cancer+1 more
University of Washington 24
Testing effectiveness (Phase 2)Study completedNCT01487863
What this trial is testing

Concurrent vs. Sequential Sipuleucel-T & Abiraterone Treatment in Men With Metastatic Castrate Resistant Prostate Cancer

Who this might be right for
Prostate Cancer MetastaticHormone Refractory Prostate CancerCastration-resistant Prostate Cancer
Dendreon 69
Testing effectiveness (Phase 2)Study completedNCT00474383
What this trial is testing

An Safety and Efficacy Study of Abiraterone Acetate in Participants With Advanced Prostate Cancer Who Failed Androgen Deprivation and Docetaxel-Based Chemotherapy

Who this might be right for
Prostate Neoplasms
Cougar Biotechnology, Inc. 47
Not applicableUnknownNCT03414437
What this trial is testing

Post-eRADicAte - A Long Term Follow up of Subjects That Completed the eRADicAte Study (NCT 02097303)

Who this might be right for
Prostate Cancer Metastatic
Carolina Research Professionals, LLC 31
Testing effectiveness (Phase 2)Study completedNCT01946165
What this trial is testing

Abiraterone Acetate Plus LHRH Agonist and Abiraterone Acetate Plus LHRH Agonist and Enzalutamide

Who this might be right for
Prostate Cancer
M.D. Anderson Cancer Center 69
Large-scale testing (Phase 3)Study completedNCT04056754
What this trial is testing

Study of Abiraterone Acetate in Subjects With Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 268
Testing effectiveness (Phase 2)Study completedNCT01088529
What this trial is testing

Neo-adjuvant Abiraterone + Luteinizing Hormone-Releasing Hormone (LHRH) Versus LHRH in Prostate Cancer

Who this might be right for
Prostate Cancer
Cougar Biotechnology, Inc. 66
Testing effectiveness (Phase 2)Ended earlyNCT01994590
What this trial is testing

Dovitinib (TKI258) and Abiraterone Acetate in Metastatic Castrate-Resistant Prostate Cancer (mCRPC)

Who this might be right for
Prostate Cancer
M.D. Anderson Cancer Center 4
Early research (Phase 1)Ended earlyNCT05295927
What this trial is testing

EPI-7386 in Combination With Abiraterone Acetate Plus Prednisone, or Apalutamide in Metastatic Castration-resistant Prostate Cancer (mCRPC)

Who this might be right for
Prostatic Neoplasms
Janssen Research & Development, LLC 3
Testing effectiveness (Phase 2)Study completedNCT02903368
What this trial is testing

Neoadjuvant And Adjuvant Abiraterone Acetate + Apalutamide Prostate Cancer Undergoing Prostatectomy

Who this might be right for
Prostate Cancer
Dana-Farber Cancer Institute 118
Large-scale testing (Phase 3)Active Not RecruitingNCT04497844
What this trial is testing

Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for the Treatment of Participants With Deleterious Germline or Somatic Homologous Recombination Repair (HRR) Gene-MutatedProstatic Neoplasms (mCSPC)

Who this might be right for
Prostatic Neoplasms
Janssen Research & Development, LLC 696
Large-scale testing (Phase 3)Active Not RecruitingNCT01957436
What this trial is testing

A Phase III Study for Patients With Metastatic Hormone-naïve Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
UNICANCER 1,173
Testing effectiveness (Phase 2)UnknownNCT01685125
What this trial is testing

Abiraterone Acetate and Prednisone With or Without Dasatinib in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer

Who this might be right for
Hormone-resistant Prostate CancerRecurrent Prostate CancerStage IV Prostate Cancer
University of Southern California 96
Testing effectiveness (Phase 2)Study completedNCT01381874
What this trial is testing

Abiraterone Acetate Plus Prednisone With or Without Exemestane in Postmenopausal Women With Estrogen Receptor-Positive (ER+) Metastatic Breast Cancer Progressing After Letrozole or Anastrozole Therapy

Who this might be right for
Metastatic ER+ Her2- Breast CancerPostmenopausal
Janssen Research & Development, LLC 297
Testing effectiveness (Phase 2)Study completedNCT01314118
What this trial is testing

IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen

Who this might be right for
Prostate CancerProstatic Neoplasm
Janssen Biotech, Inc. 131
Early research (Phase 1)Active Not RecruitingNCT02123758
What this trial is testing

JNJ-56021927 (ARN-509) and Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Prostatic NeoplasmsMetastatic Castration-Resistant Prostate Cancer
Aragon Pharmaceuticals, Inc. 57
Testing effectiveness (Phase 2)Active Not RecruitingNCT04267887
What this trial is testing

Advanced ChemoHormonal Therapy for Treatment Naive Metastatic Prostate Cancer

Who this might be right for
Castration-Sensitive Prostate CarcinomaMetastatic Prostate CarcinomaStage IVB Prostate Cancer AJCC v8
OHSU Knight Cancer Institute 7
Not applicableNo Longer AvailableNCT01834209
What this trial is testing

Abiraterone Acetate Plus Prednisone in Asymptomatic or Mildly Symptomatic Patients With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Prostate Neoplasms
Janssen Research & Development, LLC
Testing effectiveness (Phase 2)Active Not RecruitingNCT03821792
What this trial is testing

Abiraterone Acetate, Prednisone, and Apalutamide in Treating Patients With Hormone-Naive Metastatic Prostate Cancer

Who this might be right for
Metastatic Prostate CarcinomaProstate AdenocarcinomaProstate Carcinoma Metastatic in the Bone+3 more
M.D. Anderson Cancer Center 60
Next Page